Clinical Efficacy Comparison of Saccharomyces boulardii and Yogurt Fluid in Acute Non-Bloody Diarrhea in Children: A Randomized, Controlled, Open Label Study


Creative Commons License

Eren M., DİNLEYİCİ E. Ç., Vandenplas Y.

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, cilt.82, sa.3, ss.488-491, 2010 (SCI-Expanded) identifier identifier identifier

Özet

The purpose of this trial is to evaluate the clinical efficacy and cost/effectiveness of Saccharomyces boulardii compared with yogurt fluid (YF) in acute non-bloody diarrhea in children. This randomized, prospective open-label clinical trial includes 55 children (36 boys, 19 girls; mean age 21.2 +/- 28.2 months). Group A (N = 28) received lyophilized S. boulardii and group B (N = 27) received YE The duration of diarrhea was shorter with S. boidardii but the hospital stay was reduced with YF, although these differences were not significant. However, diarrhea had resolved in significantly more children on day 3 in the S. boulardii group (48.5% versus 25.5%; P < 0.05). In outpatient cases, yogurt treatment was cheaper than S. boulardii whereas in hospitalized patients, treatment cost was similar. In conclusion, the effect of daily freshly prepared YF was comparable to S. boulardii in the treatment of acute non-bloody diarrhea in children. ne duration of diarrhea was shorter in the S boulardii group, expressed as a significantly higher number of patients with normal stools on day 3.